Abstract
Even though renal failure also affects the function of white blood cells and thrombocytes (1), renal anemia is the only hematologic disturbance of uremia for which well-founded possibilities of therapeutic intervention exist today. The basis for this exceptional and fortunate situation is our advanced understanding of the pathogenesis of renal anemia as well as recent progress in molecular biology. As this book is devoted to therapy, this chapter will restrict itself to renal anemia and its management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eschbach JW: Hematologic problems of dialysis patients. In: Drukker, Parsons, Maher, eds, Replacement of Renal Function by Dialysis. Martinus Nijhoff, Boston, pp 630–645, 1983.
Neff MS, Kim KE, Persoff M, Onesti G, Swartz C: Hemodynamics of uremic anemia. Circulation 43:876–883, 1971.
Eschbach JW, Adamson JW: Anemia of end-stage renal disease. Kidney Int 28:1–5, 1985.
Bogin E, Massry SG, Levi J, Mdaldeti M, Bristol G, Smith J: Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69:1017–1025, 1982.
Akmal M, Telfer N, Ansari AN, Massry SG: Red blood cell survival in chronic renal failure: Role of secondary hyperparathyroidism. J Clin Invest 76:1695–1698, 1985.
Jacob HS, Amsden T: Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med 285:1146–1450, 1071.
Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME, Cronkite EP: Radioimmunoassay of erythropoietin: Circulating levels in normal and polycythemic human beings. J Lab Clin Med 99:624–635, 1982.
McGonigle RJS, Wallin JD, Shadduck RK, Fisher JW: Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 25:437–444, 1984.
Caro J, Brown S, Miller O, Murray T, Erslev AJ: Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 93:449–458, 1979.
Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renl failure: Relationship to degree of anemia and excretory renal function. Blood 54:877–884, 1979.
Eschbach JW, Adamson JW, Cook JD: Disorders of red blood cell production in uremia. Arch Intern Med 126:812–815, 1970.
Radtke HW, Frei U, Erbes PM, Schoeppe W, Koch KM: Improving anemia by hemodialysis: Effect on serum erythropoietin. Kidney Int 17:382–387, 1980.
Radtke HW, Rege AB, LaMarche MB, Bartos D, Bartos F, Campbell RA, Fisher JW: Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. J Clin Invest 67:1623–1629, 1981.
Meytes D, Bogin E, Ma A, Dukes PP, Massry SG: Effect of parathyroid hormone on erythropoiesis. J Clin Invest 67:1263–1269, 1981.
Segal GM, Stueve T, Adamson JW: Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis. Kidney Int 31:72–76, 1987.
Kaiser L, Schwartz KA: Aluminum-induced anemia. Am J Kidney Dis 6:348–352, 1985.
Swartz R, Dombrouski J, Burnatowska — Hledin M, Mayor G: Microcytic anemia in dialysis patients: Reversible marker of aluminium toxicity. Am J Kidney Dis 9:217–223, 1987.
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316:73–78, 1987.
Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM: Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2:1175–1177, 1986.
Duling BR, Pittman RN: Oxygen tension: Dependent or independent variable in local control of blood flow? Fed Proc 34(11):2012–2019, 1975.
Bommer J, Müller-Bühl E, Ritz E, Eifert J: Recombinant human erythropoietin in anaemic patients on haemodialysis (letter). Lancet 1:392, 1987.
Wideröe TE, Sanengen T, Halvorsen S: Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis. Kidney Int 24:208–217, 1983.
Chandra M, McVicar M, Clemons G, Mossey RT, Wilkes BM: Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis. Nephron 46:312–315, 1987.
Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N: A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304:871–875, 1981.
Hendler ED, Solomon L: Androgen therapy in hemodialysis patients: I. Effects on red cell oxygen transport. Kidney Int 31:100–106, 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Koch, K.M. (1991). Hematologic Disorders in Renal Failure. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_48
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive